NADPH oxidase 1 (NOX1), which is overexpressed in colon and prostate cancers, increases levels of VEGF, VEGF receptor, and matrix metalloproteinase 3 (MMP-3) [48]. This evidence concerns the gene MMP3 and prostate cancer.